Evaluation of Blood-based Biomarkers for Prediction of Response in Carboplatin-treated Metastatic Castration-resistant Prostate Cancer Patients

Conclusion: Carboplatin showed moderate efficacy against mCRPC in this unselected population of patients and NSE levels may help to predict the success of this treatment.

Source: In Vivo - November 3, 2020 Category: Research Authors: MORITZ, J., BAUERNHOFER, T., MANNWEILER, S., LANGSENLEHNER, T., PUMMER, K., DANDACHI, N., PICHLER, M. Tags: Clinical Studies Source Type: research